|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0980 AUD | -2.00% |
|
-2.00% | +15.29% |
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -7.33 | -9.63 | -25.09 | -42.14 | -136.74 | |||||
Return on Total Capital | -7.89 | -10.45 | -28.71 | -47.94 | -162.25 | |||||
Return On Equity % | -15.37 | -20.43 | -105.88 | -126.08 | -254.33 | |||||
Return on Common Equity | -15.37 | -20.43 | -105.88 | -126.08 | -254.33 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 93.84 | 93.03 | 65.02 | 100 | 100 | |||||
SG&A Margin | 105.34 | 105.15 | 112.61 | 290 | 408.37 | |||||
EBITDA Margin % | -30.33 | -32.22 | -80.68 | -690.89 | -1.1T | |||||
EBITA Margin % | -34.81 | -35.92 | -85.19 | -691.08 | -1.1T | |||||
EBIT Margin % | -34.81 | -35.92 | -85.19 | -691.08 | -1.1T | |||||
Income From Continuing Operations Margin % | -36.57 | -37.87 | -162.64 | -1.06T | -1.08T | |||||
Net Income Margin % | -36.57 | -37.87 | -162.64 | -911.61 | -1.08T | |||||
Net Avail. For Common Margin % | -36.57 | -37.87 | -162.64 | -1.06T | -1.08T | |||||
Normalized Net Income Margin | -22.86 | -23.67 | -53.26 | -430.11 | -674.39 | |||||
Levered Free Cash Flow Margin | -16.83 | -17.04 | -11.01 | -434.01 | -599.16 | |||||
Unlevered Free Cash Flow Margin | -15.48 | -15.81 | -9.67 | -434.01 | -599.16 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.34 | 0.43 | 0.47 | 0.1 | 0.2 | |||||
Fixed Assets Turnover | 1.04 | 1.35 | 2.36 | - | - | |||||
Receivables Turnover (Average Receivables) | 7.93 | 15.83 | 16.93 | - | - | |||||
Inventory Turnover (Average Inventory) | 0.24 | 0.31 | 2.56 | - | - | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 4.78 | 3.2 | 2.24 | 12.42 | 2.84 | |||||
Quick Ratio | 3.58 | 2.23 | 2.13 | 12 | 2.73 | |||||
Operating Cash Flow to Current Liabilities | -1.03 | -1.14 | -1.16 | -5.77 | -9.32 | |||||
Days Sales Outstanding (Average Receivables) | 46.01 | 23.06 | 21.56 | - | - | |||||
Days Outstanding Inventory (Average Inventory) | 1.51T | 1.19T | 142.47 | - | - | |||||
Average Days Payable Outstanding | 541.94 | 607.51 | - | - | - | |||||
Cash Conversion Cycle (Average Days) | 1.02T | 606.34 | - | - | - | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 14.39 | 17.66 | 26.97 | - | - | |||||
Total Debt / Total Capital | 12.58 | 15.01 | 21.24 | - | - | |||||
LT Debt/Equity | 12.74 | 13.22 | 22.9 | - | - | |||||
Long-Term Debt / Total Capital | 11.14 | 11.24 | 18.03 | - | - | |||||
Total Liabilities / Total Assets | 18.93 | 22.16 | 36.56 | 8.06 | 35.29 | |||||
EBIT / Interest Expense | -16.12 | -18.31 | -39.75 | - | - | |||||
EBITDA / Interest Expense | -12.34 | -14.75 | -35.76 | - | - | |||||
(EBITDA - Capex) / Interest Expense | -13.63 | -15.24 | -36.18 | - | - | |||||
Total Debt / EBITDA | -1.31 | -1.06 | -0.36 | - | - | |||||
Net Debt / EBITDA | 1.79 | 0.79 | 0.57 | 1.85 | 0.25 | |||||
Total Debt / (EBITDA - Capex) | -1.19 | -1.03 | -0.35 | - | - | |||||
Net Debt / (EBITDA - Capex) | 1.62 | 0.77 | 0.56 | 1.85 | 0.25 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -11.24 | 23.33 | -15.32 | -3.66 | 82.7 | |||||
Gross Profit, 1 Yr. Growth % | -11.42 | 22.27 | -40.82 | -3.66 | 82.7 | |||||
EBITDA, 1 Yr. Growth % | 1.35 | 31.02 | 112.04 | 340.04 | 191.26 | |||||
EBITA, 1 Yr. Growth % | 2.11 | 27.27 | 100.82 | 252.95 | 191.18 | |||||
EBIT, 1 Yr. Growth % | 2.11 | 27.27 | 100.82 | 252.95 | 191.18 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -1.81 | 27.73 | 263.63 | 466.09 | 86.45 | |||||
Net Income, 1 Yr. Growth % | -1.81 | 27.73 | 263.63 | 23.53 | 116.26 | |||||
Normalized Net Income, 1 Yr. Growth % | -1.81 | 27.73 | 90.53 | 268.44 | 186.47 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -7.93 | 27.27 | 259 | 389.92 | 41.85 | |||||
Accounts Receivable, 1 Yr. Growth % | -18.72 | -23.4 | -20.01 | -87.52 | - | |||||
Inventory, 1 Yr. Growth % | 17.55 | 3.46 | -100 | - | - | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -3.19 | -6.28 | -99.95 | - | - | |||||
Total Assets, 1 Yr. Growth % | 1.93 | -7.99 | -39.17 | 81.47 | -60.82 | |||||
Tangible Book Value, 1 Yr. Growth % | 5.9 | -17.49 | -83.49 | 1.21T | -72.42 | |||||
Common Equity, 1 Yr. Growth % | 4.15 | -11.67 | -50.42 | 163 | -72.42 | |||||
Cash From Operations, 1 Yr. Growth % | -26.14 | 42.04 | 17.41 | 230.43 | 176.53 | |||||
Capital Expenditures, 1 Yr. Growth % | 236.49 | -57.35 | -19.86 | - | - | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -31.3 | 24.86 | -45.28 | -676.04 | 152.22 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -31.12 | 25.98 | -48.21 | -676.04 | 152.22 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -8.28 | 4.63 | 2.2 | -56.8 | 32.67 | |||||
Gross Profit, 2 Yr. CAGR % | -7.53 | 4.07 | -14.93 | -55.21 | 32.67 | |||||
EBITDA, 2 Yr. CAGR % | -9.32 | 15.23 | 66.68 | 100.05 | 258 | |||||
EBITA, 2 Yr. CAGR % | -8.52 | 14 | 59.87 | 89.48 | 220.58 | |||||
EBIT, 2 Yr. CAGR % | -8.52 | 14 | 59.87 | 89.48 | 220.58 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -7.15 | 11.99 | 115.52 | 128.26 | 224.88 | |||||
Net Income, 2 Yr. CAGR % | -7.15 | 11.99 | 115.52 | 111.94 | 63.44 | |||||
Normalized Net Income, 2 Yr. CAGR % | -7.15 | 11.99 | 56 | 84.15 | 224.88 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -22.62 | 8.25 | 113.75 | 111.02 | 163.62 | |||||
Accounts Receivable, 2 Yr. CAGR % | -3.32 | -21.1 | -21.73 | -68.41 | - | |||||
Inventory, 2 Yr. CAGR % | 28.36 | 10.28 | - | - | - | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 18.31 | -4.75 | -97.82 | - | -4.36 | |||||
Total Assets, 2 Yr. CAGR % | 12.89 | -3.16 | -25.19 | 5.06 | -15.68 | |||||
Tangible Book Value, 2 Yr. CAGR % | 14.88 | -6.52 | -63.09 | 46.98 | 89.96 | |||||
Common Equity, 2 Yr. CAGR % | 9.14 | -4.08 | -33.82 | 14.19 | -14.84 | |||||
Cash From Operations, 2 Yr. CAGR % | -22.31 | 2.42 | 29.14 | 96.97 | 202.28 | |||||
Capital Expenditures, 2 Yr. CAGR % | -16.74 | 19.79 | -41.54 | - | -78.92 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -26.62 | -7.39 | -17.34 | 118.02 | 281.17 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -28.68 | -6.85 | -19.23 | 126.31 | 281.17 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 3.91 | 1.24 | -2.5 | -38.72 | -30.14 | |||||
Gross Profit, 3 Yr. CAGR % | 4.94 | 1.5 | -13.78 | -37.4 | -28.44 | |||||
EBITDA, 3 Yr. CAGR % | -22.81 | 2.52 | 41.21 | 73.72 | 126.73 | |||||
EBITA, 3 Yr. CAGR % | -20.46 | 2.12 | 37.68 | 65.94 | 118.66 | |||||
EBIT, 3 Yr. CAGR % | -20.46 | 2.12 | 37.68 | 65.94 | 118.66 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -19.06 | 3.27 | 65.83 | 88.1 | 113.37 | |||||
Net Income, 3 Yr. CAGR % | -19.06 | 3.27 | 65.83 | 79.03 | 113.37 | |||||
Normalized Net Income, 3 Yr. CAGR % | -19.06 | 3.27 | 33.69 | 63.01 | 113.37 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -37.33 | -8.66 | 61.43 | 78.29 | 84.85 | |||||
Accounts Receivable, 3 Yr. CAGR % | -0.87 | -10.54 | -20.74 | -57.56 | - | |||||
Inventory, 3 Yr. CAGR % | 20.65 | 19.46 | - | - | - | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 11.47 | 9.47 | -92.29 | - | -92.26 | |||||
Total Assets, 3 Yr. CAGR % | 9.43 | 5.45 | -17.06 | 0.52 | -24.38 | |||||
Tangible Book Value, 3 Yr. CAGR % | 12.5 | 2.88 | -47.56 | 21.25 | -15.86 | |||||
Common Equity, 3 Yr. CAGR % | 7.55 | 1.71 | -23.02 | 4.82 | -28.89 | |||||
Cash From Operations, 3 Yr. CAGR % | -15.43 | -5 | 7.19 | 76.63 | 120.55 | |||||
Capital Expenditures, 3 Yr. CAGR % | -51.08 | -33.38 | 4.77 | - | -67.1 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -25.32 | -12.39 | -22.29 | 81.05 | 128.87 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -27.08 | -13.79 | -23.4 | 86.17 | 134.64 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 6.11 | 6.4 | 3.22 | -27.99 | -17.89 | |||||
Gross Profit, 5 Yr. CAGR % | 6.68 | 7.18 | -3.51 | -26.83 | -16.87 | |||||
EBITDA, 5 Yr. CAGR % | -8.65 | 4.13 | 5.02 | 33.94 | 72.96 | |||||
EBITA, 5 Yr. CAGR % | -7.23 | 4.34 | 5.16 | 30.77 | 68.51 | |||||
EBIT, 5 Yr. CAGR % | -7.23 | 4.34 | 5.16 | 30.77 | 68.51 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -19.38 | 4.92 | 19.76 | 41.82 | 64.87 | |||||
Net Income, 5 Yr. CAGR % | -19.38 | 4.92 | 19.76 | 37.68 | 64.87 | |||||
Normalized Net Income, 5 Yr. CAGR % | -6.34 | 4.92 | 5.24 | 30.15 | 64.87 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -36.94 | -12.95 | 2.38 | 27.68 | 49.23 | |||||
Accounts Receivable, 5 Yr. CAGR % | 20.81 | -3.56 | -9.81 | -41.01 | - | |||||
Inventory, 5 Yr. CAGR % | 25.65 | 16.46 | - | - | - | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 13.68 | 13.18 | -76.91 | - | -78.88 | |||||
Total Assets, 5 Yr. CAGR % | 11.85 | 4.22 | -6.01 | 5.29 | -16.51 | |||||
Tangible Book Value, 5 Yr. CAGR % | 24.53 | 4.46 | -27.97 | 18.66 | -12.24 | |||||
Common Equity, 5 Yr. CAGR % | 12.07 | 2.55 | -11.44 | 6.53 | -19.85 | |||||
Cash From Operations, 5 Yr. CAGR % | -10.13 | 1.19 | 0.17 | 27.17 | 62.28 | |||||
Capital Expenditures, 5 Yr. CAGR % | -41.62 | -5.32 | -47.47 | - | -44.83 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -25.31 | -1.6 | -22.23 | 26.16 | 59.38 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -26.41 | -2.17 | -24.04 | 26.83 | 62.15 |
- Stock Market
- Equities
- NUZ Stock
- Financials Neurizon Therapeutics Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















